[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=963d814c5189270926fb628c06c0d5b1268d134bec363a1f93e40f6357bce2af",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749227700,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 135092031,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=963d814c5189270926fb628c06c0d5b1268d134bec363a1f93e40f6357bce2af"
    }
  },
  {
    "ts": null,
    "headline": "Why This 1 Value Stock Could Be a Great Addition to Your Portfolio",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=63c80783daa0214f9d2b228dc1924f8a08dd81b35b61e70ef6a2477971d04d71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749217206,
      "headline": "Why This 1 Value Stock Could Be a Great Addition to Your Portfolio",
      "id": 135083964,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=63c80783daa0214f9d2b228dc1924f8a08dd81b35b61e70ef6a2477971d04d71"
    }
  },
  {
    "ts": null,
    "headline": "Harbor Long-Term Growers ETF Q1 2025 Commentary",
    "summary": "During Q1, the Harbor Long Term Growers ETF returned -10.09% (at NAV), underperforming the benchmark, the Russell 1000Â® Growth Index, which returned -9.97%.",
    "url": "https://finnhub.io/api/news?id=548090960eab348860d22524fe342b17d9572679f102203ea573fcf9d3152656",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749213120,
      "headline": "Harbor Long-Term Growers ETF Q1 2025 Commentary",
      "id": 135080332,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2067714497/image_2067714497.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "During Q1, the Harbor Long Term Growers ETF returned -10.09% (at NAV), underperforming the benchmark, the Russell 1000Â® Growth Index, which returned -9.97%.",
      "url": "https://finnhub.io/api/news?id=548090960eab348860d22524fe342b17d9572679f102203ea573fcf9d3152656"
    }
  },
  {
    "ts": null,
    "headline": "Humana: Implied Volatility Creating A Viable Investment Case",
    "summary": "Humana: Implied Volatility Creating A Viable Investment Case",
    "url": "https://finnhub.io/api/news?id=757989e823efd9e069f49d41fb3c84d09a9b1af3c2b3471fddc876348cf761c7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749209287,
      "headline": "Humana: Implied Volatility Creating A Viable Investment Case",
      "id": 135079751,
      "image": "",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=757989e823efd9e069f49d41fb3c84d09a9b1af3c2b3471fddc876348cf761c7"
    }
  },
  {
    "ts": null,
    "headline": "Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market",
    "summary": "Autolus Therapeutics plc delivers a breakthrough CAR-T therapy for B-ALL with strong safety/efficacy. Learn more about AUTL stock here.",
    "url": "https://finnhub.io/api/news?id=0519ee6b4722d3f30fcf1667776ac0abf7779e3b2d785523bfcfb8f9dfc9524f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749208157,
      "headline": "Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market",
      "id": 135079543,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/104271852/image_104271852.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Autolus Therapeutics plc delivers a breakthrough CAR-T therapy for B-ALL with strong safety/efficacy. Learn more about AUTL stock here.",
      "url": "https://finnhub.io/api/news?id=0519ee6b4722d3f30fcf1667776ac0abf7779e3b2d785523bfcfb8f9dfc9524f"
    }
  },
  {
    "ts": null,
    "headline": "2 Reasons to Like GILD (and 1 Not So Much)",
    "summary": "While the broader market has struggled with the S&P 500 down 2.4% since December 2024, Gilead Sciences has surged ahead as its stock price has climbed by 21% to $111.47 per share. This performance may have investors wondering how to approach the situation.",
    "url": "https://finnhub.io/api/news?id=ac72a233663a0f84dd1e63bb6d532b6b7f91981914ef198059df51a0c8db00ac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749182471,
      "headline": "2 Reasons to Like GILD (and 1 Not So Much)",
      "id": 135074123,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "While the broader market has struggled with the S&P 500 down 2.4% since December 2024, Gilead Sciences has surged ahead as its stock price has climbed by 21% to $111.47 per share. This performance may have investors wondering how to approach the situation.",
      "url": "https://finnhub.io/api/news?id=ac72a233663a0f84dd1e63bb6d532b6b7f91981914ef198059df51a0c8db00ac"
    }
  }
]